Established during infancy, the initial colonisation and development of the complex gut microbial community of our gastrointestinal tract can be shaped by common medical interventions, such as caesarean section and antibiotic use. This chapter provides evidence on the gut microbial impact of four medical interventions: (1) caesarean delivery, (2) maternal intrapartum antibiotic prophylaxis (IAP), (3) hospitalisation post birth, and (4) postnatal infant antibiotic treatment. Reductions in bifidobacteria and members of the Bacteroidaceae family (e.g. Bacteroides fragilis) are by far the most common perturbations in microbial composition following each of these interventions, especially after elective or emergency caesarean section. On the other hand, genus Clostridium and the Enterbacteriaceae (e.g. Klebsiella, Escherichia coli) are likely to become more abundant in infants delivered by caesarean, exposed to maternal antibiotics, hospitalised post birth and treated with antibiotics. Often, the enterococci and staphylococci also become more abundant. Differential impact on gut microbiota is observed by type of caesarean delivery and antibiotic administered to the mother or infant. IAP with penicillin or cefazolin, or newborn treatment with intravenous penicillin (plus gentamicin) is associated with higher abundance of Enterococcus and Staphylococcus aureus. Klebsiella emerge after newborn intravenous ampicillin (plus gentamicin) treatment. The Veillonella become more abundant in the infant gut after emergency (but not elective caesarean), whereas they are found to be depleted two months after newborn treatment with oral cephalexin. Of note, dysbiosis from perinatal medical interventions also occurs in the early breastfed infant and is enhanced by prematurity.
Introduction
Women who undergo caesarean section delivery uniformly report a greater number of medical interventions, less mother-infant contact after birth and suboptimal breastfeeding practices (Chalmers et al., 2009) . As unsatisfying as they are for women and their families, they also derail the normal development of the gut microbiome during infancy. This development starts with pioneer microbes, the enterobacteria, which prepare the gut for anaerobic bacteria like bifidobacteria, Clostridia and other Firmicutes, and members of the Bacteroidetes. For a concise and comprehensive overview of all factors that affect this process, see Van Best et al. (2015) . The focus of this chapter is on medical interventions during birth and the postnatal period, and how they affect the infant gut microbiome.
Four medical interventions will be reviewed: (1) caesarean section delivery (CS); (2) maternal intrapartum antibiotic prophylaxis (IAP); (3) hospitalisation post birth (home and hospital birth); and (4) postnatal infant antibiotic treatment. Appendix 4.1 provides details on most of the studies cited in this chapter, grouped according to taxon perturbation within each of the medical interventions. By way of background, high-throughput sequenced-based studies typically report on taxon-specific microbial abundance relative to the total abundance of other microbes present in the biological sample. Culture and qPCR (polymerase chain reaction assay) studies enumerate absolute quantities of microbes, which are not reported in relative terms since quantification of all microbial species present in a sample is rarely possible with these methods. On the other hand, culture and qPCR methods enable greater reporting of microbes at the species level. All methods enable determinations of the percent colonisation with a microbe.
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Caesarean section delivery
The WHO recommendation that population rates of CS not exceed 15% has been in effect for almost 30 years (WHO, 1985) . This benchmark remains appropriate to protect the woman and foetus from life-threatening complications, and also to prevent excess maternal and neonatal morbidity and mortality (Althabe and Belizan, 2006; Karlstrom et al., 2013) . Currently in North America and Europe, 24 and 19% of births, respectively, are by CS; at 29%, Latin America has the highest global rates (Betran et al., 2016) . CS rates are rising despite a lack of evidence for increasing prevalence of obstetric emergencies or medical risk (Bailit et al., 2004; MacDorman et al., 2008) . The convenience of scheduling birth and fear of pain are contributing factors (Holmgren et al., 2012; Miesnik and Reale, 2007) . Also, contrary to WHO guidelines, less than 30% of infants in middle-income countries are exclusively breastfed for the first 5 months of life (Victora et al., 2016) , and less so if they are born by CS (Al-Sahab et al., 2010) . The consequences of CS birth should not be underestimated. Women undergoing CS are at greater risk for haemorrhage and uterine rupture (Armson, 2007; Liu et al., 2007) , and their newborns have higher rates of respiratory distress and infection (Karlstrom et al., 2013; Magnus et al., 2011) . Beyond maternal and neonatal risks, a number of risks to child health have been linked to CS birth, including food allergy (Sanchez-Valverde et al., 2009) , asthma (Huang et al., 2015) and overweight (Li et al., 2013) .
Impact on infant gut microbiota: summary of evidence
No less than 7 cohort studies around the world have documented reduced faecal abundance of genus Bacteroides or reduced diversity of the phylum Bacteroidetes in infants up to 4 months following caesarean delivery. This evidence comes from 5 European (n=1,853) and 2 North American cohorts (n=300) (Backhed et al., 2015; Hesla et al., 2014; Jakobsson et al., 2014; Madan et al., 2016; Penders et al., 2006 Penders et al., , 2013 . Bifidobacteria are also less abundant and less diverse in the newborn gut within one week after CS (Backhed et al., 2015; Dogra et al., 2015; Penders et al., 2006) , while the staphylococci are more plentiful (Backhed et al., 2015; Madan et al., 2016; Stokholm et al., 2016) . Maternal skin has been identified as the source of staphylococci at birth in caesarean-delivered infants (Dominguez-Bello et al., 2010) . Finally, Clostridium difficile has also been found to a greater extent in the stools of caesarean versus vaginally-delivered infants within one month after birth (Penders et al., 2006) . Colonisation of the infant gut with C. difficile is becoming increasingly more prevalent than it was in the 1980s (Adlerberth and Wold, 2009) , especially following CS (Adlerberth et al., 2014) . While microbial changes have been detected up to 7 years following CS (Salminen et al., 2004) , C. difficile colonisation as soon as 1 month after birth has been found to mediate the association between caesarean-induced gut dysbiosis and atopic disease (Penders et al., 2013; Van Nimwegen et al., 2011) .
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Differences between elective and emergency caesarean
Emergency and elective caesarean differ by indication, with foetal distress a common feature in the former. As well, many emergency caesareans are performed after a trial of labour, exposing newborns to maternal vaginal microbes. Unfortunately, most published studies do not separately report on elective versus emergency caesarean or even the percentage contribution for each to the study population. Among the few publications to date (Azad et al., 2016; Stokholm et al., 2016) , gut microbiota profiles before three months of age in infants delivered by emergency CS were found to differ from those following elective CS; in the Canadian Healthy Infant Longitudinal Development (CHILD) cohort, this difference was independent of breastfeeding status (Azad et al., 2016) . Based on culture methods, a higher percentage of neonates were colonised with Citrobacter freundii and S. aureus one week after emergency than elective CS (or vaginal birth) in the COPSAC 2010 cohort; by one month of age, Citrobacter colonisation rates were equivalent between elective and emergency caesarean (Stokholm et al., 2016) . Relative to vaginal birth in two Swedish cohorts, the faecal abundance of Veillonella species was higher at age 1-3 weeks in mixed samples of infants delivered by elective and emergency CS (Hesla et al., 2014; Jakobsson et al., 2014) . Among infants in the CHILD cohort, the Veillonella were more abundant in faecal samples at three months following emergency CS than vaginally delivery; these differences were not seen for elective CS (Azad et al., 2016) .
Common findings for elective and emergency caesarean
Certainly, varying indications for CS across studies may contribute to conflicting findings. In addition, culture-based studies are less effective in detecting strict anaerobes, such as the Bacteroides species (Stokholm et al., 2016) . Notwithstanding these differences, the relative abundance of infant faecal Bacteroidetes (from the CHILD sequence-based study) was substantially reduced at 3 months of infant age following elective and emergency CS (Azad et al., 2016) . Faecal enterobacteria were also more abundant in both types of this surgical intervention (Azad et al., 2016; Backhed et al., 2015; Stokholm et al., 2016) . Interestingly, Stokholm et al. (2016) observed opposing results for individual species of cultured enterobacteria that were common to emergency and elective CS; a higher proportion of infants were colonised with Klebsiella within one month after delivery, while Escherichia coli were detected less often in faecal samples (Stokholm et al., 2016) . Klebsiella species were also found to be more abundant in the newborn gut following CS in the GUSTO cohort (Dogra et al., 2015) . Finally, Enterococcus becomes more abundant in the infant gut at one or three months following emergency and elective CS (Azad et al., 2016; Stokholm et al., 2016) ; Stokholm et al. (2016) also reported greater colonisation of the infant hypopharyngeal microbiome with Enterococcus faecalis three months after CS delivery.
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Conclusions
Against a backdrop of climbing rates of CS, evidence is accumulating on the impact of CS on the infant gut microbiome. While the mechanism for how CS increases the risk of disease is not well understood, perturbations in infant gut microbial ecology, such as lowered abundance of the genus Bacteroides, likely play a role. Beyond its direct impact on microbial exposure, CS normally requires antibiotic prophylaxis, may follow microbial colonisation from prelabour rupture of membranes (DiGiulio, 2012) and can delay onset of breastfeeding (Brown and Jordan, 2013; McDonald et al., 2012) . Noteworthy is that before three months of age, the impact of CS on gut microbial composition has been found to be stronger than breastfeeding (Madan et al., 2016) and to be independent of breastfeeding status (Azad et al., 2016) .
Maternal intrapartum antibiotics
Less well-studied is the impact of maternal intrapartum antibiotic prophylaxis (IAP) on infant gut microbiota, despite the fact that almost 40% of newborn infants are indirectly exposed to antibiotics administered during vaginal delivery (Fairlie et al., 2013; Persaud et al., 2015; Stokholm et al., 2013) . In North America, IAP constitutes a standard of care to prevent early-onset neonatal Group B Streptococcus (GBS) sepsis and maternal infection post CS (Van Schalkwyk, 2010) . It is also becoming a routine part of the birthing process subsequent to climbing rates of CS delivery and GBS colonisation in pregnancy (Johri et al., 2006) . However, IAP is not routinely practised across the globe. While North American guidelines recommend IAP following universal vaginal screening for GBS, those from the UK and Australia advocate for risk-based management approaches (Homer et al., 2014) . The adoption of a non-culture risk factor approach for GBS in Denmark has reduced IAP to 13% of vaginal deliveries (Stokholm et al., 2013) . In contrast, 27% of vaginal deliveries or more than 85% of GBS-culture positive pregnancies result in IAP in Canada and the US (Fairlie et al., 2013; Persaud et al., 2015) .
Consequences for offspring health
Effective in preventing early-onset neonatal sepsis, IAP for GBS has been linked to amoxicillinresistant late-onset E. coli infections in hospitalised infants up to 90 days after birth (Didier et al., 2012) . In the long-term, infant antibiotic treatment is associated with childhood asthma and obesity (Azad et al., 2014; Penders et al., 2011) , conditions also linked to gut dysbiosis in early life (Penders et al., 2007; Vael et al., 2011) . While this evidence originates from studies of postnatal antibiotic use, IAP disruption of initial gut colonisation of the newborn has greater potential to alter the natural succession of microbiota throughout infancy.
Impact on infant gut microbiota: summary of evidence
Findings on IAP in vaginal birth provide the main evidence for IAP independence from CS since, with few exceptions, for example in Norway (Opoien et al., 2007) , all women undergoing elective CS receive IAP. In a study of 84 full-term Italian newborns born vaginally, Aloisio et al. (2014) found lower faecal bifidobacterial counts seven days after maternal IAP with intravenous ampicillin for GBS than in its absence. In a follow-up study of these infants, bifidobacteria were no longer reduced in number at 30 days post IAP. No differences were seen in faecal concentrations of lactobacilli or Bacteroides fragilis at seven or 30 days (Corvaglia et al., 2016) . In a smaller scale comparison by Arboleya et al. (2015) , exclusively-breastfed full-term infants exposed to IAP (single dose of ampicillin) and hospitalised for three days exhibited an IAP effect between two and 90 days after birth, namely reduced abundance of Bifidobacteriaceae and Bacteroidaceae relative to controls.
Recently published from the CHILD cohort at three months of age, Azad et al. (2016) reported lowered abundance of Bacteroidaceae in faecal samples of full-term infants delivered vaginally after maternal IAP with penicillin (n=40) versus no IAP (n=96). Statistical significance was also found at the Bacteroides or Parabacteroides species level, but it did not survive correction for multiple testing. The family Clostridiaceae but not individual Clostridium species were more abundant following vaginal IAP. Compared to the infant gut dysbiosis seen following elective and emergency caesarean, there were fewer taxon differences at the genus level with IAP. Stokholm et al. (2016) also observed fewer changes with vaginal birth IAP than CS in their term infants at age one month, manifested as greater colonisation with Klebsiella and Staphylococcus species.
Interactive effects with gestational age and breastfeeding status
While studies of full-term infants indicate that IAP has a less profound effect on gut microbes than CS delivery, the impact of IAP may vary by gestational maturity. In the preterm context (mean gestational age of 30 weeks, primarily CS birth and hospitalisation for 50 days), Arboleya et al. (2015) observed several changes to gut microbial composition following maternal IAP. To begin with, all preterm infants had a much lower abundance of Bacteroidetes than term infants throughout the 3-month study. A large IAP effect was not evident at two days after birth, when only Leuconostaceae were more abundant in preterm infants not exposed to either IAP or postnatal antibiotics (e.g. ampicillin/gentamicin). Rather it emerged 30 days later, when significant clustering by IAP status was observed; infants exposed to IAP exhibited a lower relative abundance of Bifidobacteriaceae, Lactobacillales and Streptococcaceae, and a higher abundance of Enterobacteriaceae relative to non-exposed infants. At this postnatal age, no differences were observed between IAP-exposed and non-exposed infant with respect to gestational age, birth weight or length of hospital stay. The IAP impact was greater than direct administration of antibiotics to the infant.
As with CS, the impact of IAP in vaginal delivery on gut microbiota is also evident in the early breastfed infant. Azad et al. (2016) found genus Clostridium to be more abundant in IAP-exposed than non-exposed vaginally-born term infants who were exclusively breastfed at three months; the Clostridia did not vary by IAP status in partially breastfed infants. Findings from Corvaglia et al. (2016) show that IAP of vaginal birth mitigates faecal enrichment with bifidobacteria that
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is normally seen with exclusive breastfeeding at 7 days after birth; increases to lactobacilli with breastfeeding were unaffected at seven or 30 days after birth in their study.
Hospitalisation post birth
Anywhere between 11% and 27% of infants, born by emergency and elective CS respectively, are hospitalised beyond one day in Western Europe (Penders et al., 2006) . In Canada (and the US), almost 100% of these infants stay for at least two days (Tun, 2016) . Up to 62% of newborns born vaginally remain in hospital for longer than one day.
The isolation of pathogenic bacteria from the hands and clothing of hospital staff suggests that patients, as well as hospital staff, are in close proximity to antibiotic-resistant strains of bacteria namely: methicillin-resistant S. aureus (MRSA), vancomycin-resistant Enterococcus (VRE), Pseudomonas, Acinetobacter and Clostridium (Weber et al., 2013) . While many have published on hospital-based antibiotic resistance, impact on the gut microbial composition of the newborn is a new field of inquiry. Furthermore, unlike in the adult, pathogens like C. difficile have higher colonisation rates in infants in the absence of obvious gastrointestinal adverse effects (Adlerberth et al., 2014) ; a variety of maternal and household factors have promoted colonisation with this organism, such as birth mode, extent of breastfeeding, maternal parity and household pets (Azad et al., 2013; Bridgman et al., 2016) .
Home birth: impact on infant gut microbiota
Vaginal birth at home relative to the hospital setting has been shown to strikingly reduce the risk of asthma at age seven and to food sensitisation at age one in offspring of parents with allergic disease (Van Nimwegen et al., 2011) . In the same study from the KOALA cohort, the presence of C. difficile in the gut one month after birth was found to mediate the association between birth site (home versus hospital) and childhood asthma. In fact, findings from the Swedish ALADDIN cohort indicate that relative to a home birth, being born vaginally in a hospital alters the composition of the whole gut microbial community six months later (Hesla et al., 2014) .
Hospital birth: impact on infant gut microbiota
Extended hospitalisation post birth to two days or longer further alters gut microbial composition of infants. In the KOALA cohort, the two largest changes to one-month microbial composition after extended hospitalisation were increases to the colonisation rates and microbial counts for C. difficile, and reductions in the colonisation and counts for Bifidobacteriaceae (Penders et al., 2006) . Among infants hospitalised for 2-3 days versus same day discharge, E. coli were more common in faecal samples one month later. When hospital length-of-stay was longer at 4-6 days, the B. fragilis were reduced in number. Duration of hospitalisation remained a significant determinant for detecting C. difficile in infant faecal samples, independent of maternal antibiotic use, birth mode, infant feeding and other home environment factors. Each additional day of hospitalisation after birth increased the likelihood of C. difficile colonisation by 1.13 (95% CI: 1.01-1.25) (Penders et al., 2006) .
More recently, in the CHILD cohort study we reported depletion of specific gut microbiota at three months according hospitalisation post birth and this depended on birth mode (Tun, 2016) . The relative abundance of Bacteriodetes was inversely proportional to the duration of hospital stay for each birth type. Only following elective caesarean delivery was the correlation between abundance of Bacteroidaceae or Bacteroides and hospital length-of-stay statistically significant (r=-0.27, P<0.01). Put together, these observations suggest a role for hospital-acquired microbes such as C. difficile, and reduced colonisation resistance, in modifying community gut composition (Rousseau et al., 2011) .
Infant postnatal antibiotics
After breast milk and other dietary supplements, antibiotics are the next most commonly ingested substances by infants. Antibiotics affect colonisation of the intestine by suppressing commensal bacteria and causing the emergence of resistant pathogens. Despite a plethora of published articles relating infant antibiotic treatment to development of allergic disease , and more recently overweight in children (Azad et al., 2014) , evidence for the impact of infant antibiotic treatment on gut microbial composition is less plentiful.
Antibiotic treatment of infant: impact on gut microbiota
Oral amoxicillin is the drug of choice for acute otitis media and other respiratory infections in infants. When given to older infants between the ages of 1-2 years, Mangin et al. (2010) found a reduction in the number of different bifidobacterial species in faecal samples immediately at the end of the antibiotic course compared to baseline. Total bifidobacterial concentrations were unchanged and other gut microbiota were not assessed. In contrast, intravenous (IV) treatment of 6-month old infants for five days with ceftriaxone (an antibiotic excreted in bile) for pneumonia (Savino et al., 2011) , resulted in a significant reduction in total faecal bacterial counts at the end of treatment. Faecal concentrations of the Enterobacteriaceae and enterococci in these full-term infants were also reduced compared to baseline. After five days of ceftriaxone therapy, lactobacilli were no longer detected in infant faecal samples (Savino et al., 2011) .
Among young infants at 1-3 months of age, most oral antibiotics (penicillins, cephalosporins, macrolides) cause gut microbial changes 3-5 days after the cessation of treatment (Bennet et al., 2002) . These changes are evident in vaginally-born, breastfed infants; reductions to bifidobacteria, lactobacilli and Bacteroides are the most profound. Similarly, in the KOALA cohort of predominantly vaginally-born and exclusively breastfed infants at age one month, Penders et al. (2006) observed lower faecal counts of bifidobacteria and B. fragilis as determined by qPCR in those previously treated with oral antibiotics. Within a European consortium of birth cohorts, of which three-quarters of infants were delivered vaginally but only 50% had been 4. Medical interventions impact infant gut microbes exclusively breastfed, Fallani et al. (2010) reported greater abundance of faecal enterobacteria among infants receiving antibiotics by six weeks of age. No gut dysbiosis was observed in these infants in the period after breastfeeding cessation.
Intravenous antibiotic treatment of the neonate for suspected sepsis immediately after birth can significantly and persistently alter gut microbial composition. Using sequenced-based methods, Fouhy et al. (2012) reported that a 48 hour course of IV ampicillin and gentamicin in full-term newborns significantly elevated the abundance of the Proteobacteria phylum compared to controls, and lowered proportions of genus Bifidobacterium and Lactobacillus four weeks after the cessation of treatment. Bacteroidetes were also detected less often in antibiotic-treated infants. By week eight, the faecal abundance of Bifidobacterium and Lactobacillus returned to levels comparable to control infants. Yet, levels of Proteobacteria remained significantly higher and the number of different Bifidobacterium species remained low in antibiotic-treated infants. A reduction in gut microbial diversity was also observed in the Tanaka et al. (2009) study of Japanese full-term newborns hospitalised for one week and supplemented with formula. Unlike the typical IV regimen, neonates received oral cephalexin for four days after birth. Gut microbial diversity was reduced on the third day of treatment and remained lowered two months later. These community changes were accompanied by the appearance of Enterococcus faecium, and reductions in genus Bifidobacterium and Veillonella, and in members of the Bacteroidaceae family; the latter two microbial taxa were not detected at two months of age.
Using a cross-over design of rectal cultures, Parm et al. (2010) nicely demonstrated that antibiotic type determines the extent of colonisation by individual species. Treatment of preterm newborns with an IV penicillin G and gentamicin regimen resulted in colonisation of the gut with S. aureus and Enterococcus species 5-7 days after treatment, while combined treatment with ampicillin and gentamicin favoured colonisation by other staphylococci. Moreover, the ampicillin regimen resulted in a greater duration of colonisation with Klebsiella pneumonia and ampicillin-resistant Serratia (both members of the Proteobacteria). Similarly, Lindberg et al. (2011) reported a negative association between antibiotic treatment (with broad spectrum beta-lactams) and S. aureus colonisation rate in six month old Italian infants. This correlation was not seen in Swedish infants who were mainly treated with the narrow spectrum penicillin V, without activity against S. aureus.
Indirect exposure from breast milk
Maternal postnatal antibiotics are an understudied source of antibiotic exposure to infants. Although most beta-lactams are considered safe during breastfeeding, the presence of even small quantities of antibiotics in breast milk can potentially alter infant gut microbiota (Soto et al., 2014) . In the CHILD cohort, where postnatal antibiotics were mostly administered to women after an emergency CS, a higher abundance of genus Clostridium at three months of age after emergency CS was observed in exclusively breastfed but not among infants supplemented with formula (Azad et al., 2016) .
Conclusions
Clearly, emergency CS is medically indicated, antibiotics are needed to treat and prevent infection, and breastfeeding has a multitude of benefits. In this review, we presented evidence that gut dysbiosis in the developing infant occurs after common medical interventions in the perinatal time period. Reductions in bifidobacteria and members of the Bacteroidaceae family (e.g. B. fragilis) are by far the most common perturbations in microbial composition following exposure to IAP, hospitalisation post birth and treatment with antibiotics, and especially after elective or emergency caesarean delivery. On the other hand, genus Clostridium and Enterbacteriaceae (e.g. Klebsiella, E. coli) are likely to become more abundant in infants following these exposures. Often, the enterococci and staphylococci also become more abundant. Differential impact on gut microbiota is observed by type of caesarean delivery and antibiotic administered to the mother or infant. IAP with penicillin or cefazolin, or newborn treatment with IV penicillin (plus gentamicin) is associated with higher abundance of Enterococcus and S. aureus. Klebsiella emerge after newborn IV ampicillin (plus gentamicin) treatment. The Veillonella become more abundant after emergency but not elective caesarean, whereas they are found to be depleted two months after newborn treatment with oral cephalexin. Of note, dysbiosis from perinatal medical interventions also occurs in the early breastfed infant and is enhanced by prematurity.
While findings from the CHILD cohort suggest that early breastfeeding may modify IAP and CS-associated dysbiosis of the gut microbiome later in infancy (Azad et al., 2016) , not all IAPinduced dysbiosis can be 'restored' with breastfeeding (Corvaglia et al., 2016) . Reported reversals to dysbiosis, for example to Enterobacteriaceae, after the discontinuation of antibiotic treatment (Jakobsson et al., 2014) , may also be subsequent to emerging resistant strains and not continued breastfeeding. Indeed, higher abundance of these gram-negative microbiota at six months of age has been associated with higher adiposity among toddlers (Dogra et al., 2015) . Higher ratios in the abundance of the Enterobacteriaceae to Bacteroidaceae have also been reported to predict food sensitisation in infants (Azad et al., 2015) . Finally, readers should bear in mind that gut microbial alterations, which occur during critical windows in the development of the immune system, even minor perturbations, may have long-term consequences (Cox et al., 2014) . 
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Medical interventions impact infant gut microbes Appendix 4.1 Study details of infant gut microbial dysbiosis by medical intervention type and taxon category.
Microbial group Citation Study details, methods and findings
Caesarean section (CS)
Bacteroidetes ( Observed microbial change at infant age
• ↓ Bifidobacterium species richness at birth and 4 months in CS vs vaginal birth Study groups and number of infants • Vaginal (n=98) no IAP (90%), emergency CS (n=15) Infant population
• Cohort, full term, Swedish, antibiotic prophylaxis for GBS before delivery not intrapartum; 67% CS antibiotics given after cord clamp; 69% exclusively breastfed until 4 months; postnatal antibiotics in 5% of vaginal births Microbial profiling method
• HiSeq of genome contigs Penders at al. 2006 Observed microbial change at infant age • Cohort, full term, Swedish, antibiotic prophylaxis for GBS before delivery not intrapartum; 67% CS antibiotics given after cord clamp; 69% exclusively breastfed until 4 months; postnatal antibiotics in 5% of vaginal births • HiSeq of genome contigs Madan et al., 2016 Observed microbial change at infant age
• ↑ Staphylococcus abundance at 6 weeks in CS vs vaginal birth, independent of breastfeeding status Study groups and number of infants • Vaginal +/-IAP (n=70), elective/emergency CS (n=32) Infant population
• Cohort, full term, US, 69% exclusively breastfed at 6 weeks; no postnatal antibiotics Microbial profiling method
• Illumina MiSeq at V4/V5
• FDR correction Stokholm et al., 2016 Observed microbial change at infant age • Illumina MiSeq at V4
• FDR correction Stokholm et al., 2016 Observed microbial change at infant age DGGE Parm et al., 2010 Observed microbial change at infant age
• ↑ % colonisation by Enterococcus 5-7 days after treatment in penicillin vs ampicillin regimen Study groups and number of infants • At birth, course of IV penicillin/gentamicin (n=71); ampicillin/ gentamicin (n=68) Infant population
• Cross over design, preterm infants, Estonia Microbial profiling method
• Bacterial culture on specific media Tanaka et al., 2009 Observed microbial change at infant age
Microbial group Citation Study details, methods and findings
Staphylococcus
• ↑ % colonisation by Staphylococcus at end of treatment Study groups and number of infants • At birth, oral cephalexin for 4 days (n=5); no antibiotics (n=18) Infant population • Post antibiotics with controls, full term infants vaginally born and partially breastfed Microbial profiling method
• V2 by DGGE Parm et al., 2010 Observed microbial change at infant age
• ↑ % colonisation Staphylococcus aureus 5-7 days after treatment in penicillin vs ampicillin regimen Study groups and number of infants • At birth, course of IV penicillin/gentamicin (n=71); ampicillin/ gentamicin (n=68) Infant population
• Cross-over design, preterm infants, Estonia Microbial profiling method
• Bacterial culture on specific media Proteobacteria (phylum), Enterobacteriaceae (family) and Klebsiella (genus) Fouhy et al., 2012 Observed microbial change at infant age
• ↑ Proteobacteria, Enterobacteriaceae at 4 and 8 weeks post treatment Study groups and number of infants • At birth, course of IV ampicillin/gentamicin (n=9); no antibiotics (n=9) Infant population
• Post antibiotics with controls, full term, 72% vaginal birth; 44% breastfed Microbial profiling method
• 16S rRNA and rpoB-specific primers; quantitative PCR Tanaka et al., 2009 Observed microbial change at infant age
• ↑ % colonisation by Enterobacteria 3 weeks after treatment
Study groups and number of infants • At birth, oral cephalexin for 4 days (n=5); no antibiotics (n=18) Infant population • Post antibiotics with controls, full term infants vaginally born and partially breastfed Microbial profiling method • V2 by DGGE Bennet et al., 2002 Observed microbial change at infant age
• ↑ counts of Klebsiella 3-5 days after treatment Study groups and number of infants • Oral amoxil (n=9), no antibiotics (n=18) Infant population • Post antibiotics with controls, all Swedish infants vaginally born and breastfed at 1-3 months of age Microbial profiling method
• Bacterial culture on specific media
